Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (Q34501650)

1 October 2017

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (English)

1 reference

proliferative diabetic retinopathy

1 October 2017

1 reference

1 reference

1 reference

Adam R Glassman

1 reference

1 October 2017

Lee M Jampol

1 reference

1 October 2017

Neil M Bressler

1 reference

1 October 2017

Roy W Beck

1 reference

1 October 2017

Writing Committee for the Diabetic Retinopathy Clinical Research Network

1 reference

1 October 2017

Jeffrey G Gross

1 reference

1 October 2017

Seidu Inusah

1 reference

1 October 2017

Lloyd Paul Aiello

1 reference

1 October 2017

Andrew N Antoszyk

1 reference

1 October 2017

Carl W Baker

1 reference

1 October 2017

Brian B Berger

1 reference

1 October 2017

David Browning

1 reference

1 October 2017

Michael J Elman

1 reference

1 October 2017

Frederick L Ferris

1 reference

1 October 2017

Scott M Friedman

1 reference

1 October 2017

Dennis M Marcus

1 reference

1 October 2017

Michele Melia

1 reference

1 October 2017

Cynthia R Stockdale

1 reference

1 October 2017

Jennifer K Sun

1 reference

1 October 2017

language of work or name

English

0 references

publication date

13 November 2015

1 reference

The Journal of the American Medical Association

1 October 2017

1 reference

1 October 2017

314

1 reference

1 October 2017

1 reference

1 October 2017

2137-2146

1 reference

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Intravitreal aflibercept for diabetic macular edema

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Long-term effects of ranibizumab on diabetic retinopathy severity and progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Visual acuity as an outcome measure in clinical trials of retinal diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567801

Angiogenic pathways in diabetic retinopathy

9 December 2018

1 reference

12 December 2020

Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Easy SAS calculations for risk or prevalence ratios and differences

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2015.15217

1 reference

1 October 2017

1 reference

1 October 2017

PubMed publication ID

26565927

1 reference